MSCI公布半年度股指评估结果
MSCI公布半年度股指评估结果,所有变动将在今年5月27日收市时生效。
MSCI中国A股在岸指数将新增26支成份股,并删除77支。
其中最大的三支新 增成份股为:宝丰能源A股、康龙化成A股及东方盛虹。
MSCI中国A股在岸小盘股指数将新增200支成份股,删除213支。
MSCI中国全股票指数将新增60支成份股,并删除26支。
其中最大的三支新增成份股为:赣锋锂业H股、宝丰能源A股及康龙化成A股。
MSCI中国全股票小盘股指数将新增195支成份股, 删除275支。
MSCI香港指数新增周大福和富途控股ADR。
删除ASM PACIFIC TECHNOLOGY和电讯盈科。
MSCI台湾指数新增阳明海运,删除群光电子和兴富发建设。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.